0,929  0,002  Dopamine D1 antagonist
0,903  0,002  Muscle relaxant
0,867  0,002  Skeletal muscle relaxant
0,846  0,004  Respiratory analeptic
0,827  0,002  Antiparkinsonian, rigidity relieving
0,823  0,003  5 Hydroxytryptamine release stimulant
0,776  0,003  Dopamine D2 agonist
0,750  0,004  Dopamine antagonist
0,731  0,003  Dopamine agonist
0,729  0,007  Analeptic
0,707  0,004  Dopamine D2 antagonist
0,681  0,003  Alpha 2 adrenoreceptor antagonist
0,684  0,009  CYP1A2 substrate
0,695  0,024  Caspase 9 stimulant
0,673  0,005  Cardiodepressant
0,684  0,019  CYP3A4 substrate
0,655  0,004  5 Hydroxytryptamine 7 antagonist
0,654  0,012  Antiparkinsonian
0,642  0,004  Sigma receptor agonist
0,652  0,016  CYP2C9 substrate
0,640  0,010  Spasmolytic
0,610  0,005  Genotoxic
0,612  0,015  Antidepressant
0,608  0,012  CYP2D6 substrate
0,623  0,029  Transcription factor NF kappa B inhibitor
0,599  0,008  Hypoxia-inducible factor 1 alpha inhibitor
0,589  0,003  Dopamine D5 antagonist
0,588  0,005  Alpha adrenoreceptor antagonist
0,592  0,011  Histamine release inhibitor
0,585  0,005  5 Hydroxytryptamine 2 antagonist
0,586  0,007  CYP2D6 inhibitor
0,584  0,019  Mood disorders treatment
0,567  0,012  CYP2C19 inhibitor
0,558  0,005  5 Hydroxytryptamine antagonist
0,555  0,004  Alpha 2a adrenoreceptor antagonist
0,555  0,004  5 Hydroxytryptamine 2A antagonist
0,537  0,005  Male reproductive disfunction treatment
0,555  0,031  15-Lipoxygenase inhibitor
0,522  0,004  Alpha 2b adrenoreceptor antagonist
0,522  0,004  Pneumotoxic
0,531  0,027  Prostate cancer treatment
0,506  0,005  Erectile dysfunction treatment
0,504  0,004  Tyrosine 3 hydroxylase inhibitor
0,499  0,004  Neurotrophic factor enhancer
0,550  0,060  Apoptosis agonist
0,484  0,004  Dopamine D3 antagonist
0,490  0,012  Psychostimulant
0,481  0,005  5 Hydroxytryptamine 1A antagonist
0,494  0,021  Caspase 3 stimulant
0,472  0,005  5 Hydroxytryptamine 1 antagonist
0,463  0,004  Alpha 2c adrenoreceptor antagonist
0,462  0,008  Antiseptic
0,476  0,023  UGT1A9 substrate
0,447  0,011  Cyclic AMP phosphodiesterase inhibitor
0,437  0,006  Acetylcholine antagonist
0,437  0,006  Cholinergic antagonist
0,438  0,018  Vasodilator
0,465  0,051  Antineoplastic (lung cancer)
0,418  0,005  Antitussive
0,414  0,004  5 Hydroxytryptamine 1E antagonist
0,411  0,006  Antiparkinsonian, tremor relieving
0,439  0,035  Antipsychotic
0,431  0,038  Antihypercholesterolemic
0,414  0,025  DNA damaging
0,425  0,036  Hepatic disorders treatment
0,441  0,052  Antileukemic
0,403  0,015  Abortion inducer
0,412  0,029  Mutagenic
0,389  0,006  Acetylcholine M1 receptor antagonist
0,442  0,068  Antineoplastic (breast cancer)
0,394  0,021  Antineoplastic enhancer
0,381  0,011  Topoisomerase II inhibitor
0,416  0,050  Vasodilator, peripheral
0,382  0,019  Anesthetic general
0,382  0,021  Sedative
0,377  0,026  Pyruvate kinase inhibitor
0,363  0,014  Antineoplastic (squamous cell carcinoma)
0,348  0,003  Restless leg syndrome treatment
0,346  0,009  Toxic, respiratory center
0,341  0,005  Opioid kappa receptor antagonist
0,373  0,045  CYP2C19 substrate
0,337  0,011  Antiadrenergic
0,336  0,012  5 Hydroxytryptamine 2B antagonist
0,332  0,009  Topoisomerase I inhibitor
0,358  0,037  Antipyretic
0,321  0,005  LDLR expression enhancer
0,373  0,059  Antineoplastic (colorectal cancer)
0,336  0,023  P-glycoprotein inhibitor
0,359  0,047  CYP3A4 inhibitor
0,319  0,008  Acetylcholine muscarinic antagonist
0,342  0,032  Dependence treatment
0,321  0,012  Adrenaline antagonist
0,364  0,057  Antineoplastic (colon cancer)
0,343  0,045  Sensitization
0,299  0,004  5 Hydroxytryptamine 5A antagonist
0,348  0,053  Cardioprotectant
0,332  0,040  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,315  0,026  Hepatoprotectant
0,291  0,003  Prolactin inhibitor
0,293  0,007  Acetylcholine nicotinic antagonist
0,290  0,012  Alpha 1 adrenoreceptor antagonist
0,281  0,003  Antineoplastic alkaloid
0,341  0,064  Antihypertensive
0,325  0,051  Antineoplastic (small cell lung cancer)
0,350  0,083  Prostaglandin dehydrogenase inhibitor
0,287  0,021  Cholinergic
0,337  0,071  Bone diseases treatment
0,345  0,081  Stroke treatment
0,325  0,062  Antineoplastic (melanoma)
0,322  0,060  Radioprotector
0,273  0,011  Uterine stimulant
0,313  0,056  FMO3 substrate
0,261  0,004  5 Hydroxytryptamine 5 antagonist
0,300  0,047  Antineoplastic (glioblastoma multiforme)
0,299  0,052  Antineoplastic (liver cancer)
0,300  0,053  Dyrk kinase inhibitor
0,248  0,006  Neuronal nicotinic receptor antagonist
0,249  0,008  Opioid antagonist
0,300  0,061  Antihypoxic
0,311  0,073  12-Lipoxygenase inhibitor
0,254  0,017  CDC-like kinase 1 inhibitor
0,271  0,034  Antialcoholic
0,252  0,017  Psychosexual dysfunction treatment
0,294  0,060  Antineoplastic (glioma)
0,253  0,020  Acetylcholinesterase inhibitor
0,236  0,008  5 Hydroxytryptamine 1F antagonist
0,246  0,019  Carcinogenic, group 1
0,231  0,006  Opioid mu receptor antagonist
0,287  0,067  Antioxidant
0,233  0,013  Alpha 1a adrenoreceptor antagonist
0,236  0,018  Alkylator
0,222  0,004  Alpha 2 adrenoreceptor agonist
0,312  0,099  Cognition disorders treatment
0,331  0,119  Analgesic
0,275  0,067  Flavin-containing monooxygenase substrate
0,228  0,022  Antiviral (Hepatitis B)
0,266  0,062  Free radical scavenger
0,246  0,043  UGT2B7 substrate
0,233  0,032  Antiischemic, cerebral
0,288  0,089  Antineoplastic (brain cancer)
0,206  0,008  Alpha adrenoreceptor agonist
0,219  0,021  DNA intercalator
0,267  0,071  Teratogen
0,259  0,063  Antineoplastic (lymphoma)
0,201  0,007  Antiviral (Papilloma)
0,222  0,031  Tubulin antagonist
0,210  0,019  Antismoking
0,227  0,038  UGT1A3 substrate
0,240  0,052  UDP-glucuronosyltransferase substrate
0,271  0,084  Antineoplastic (ovarian cancer)
0,194  0,010  Analgesic, opioid
0,255  0,071  NOS2 expression inhibitor
0,254  0,070  Acute neurologic disorders treatment
0,213  0,028  ATPase inhibitor
0,195  0,012  Opioid delta receptor antagonist
0,191  0,008  CDC-like kinase 3 inhibitor
0,235  0,053  UGT1A1 substrate
0,219  0,037  Liver fibrosis treatment
0,242  0,063  Antimitotic
0,184  0,005  Phosphodiesterase XI inhibitor
0,184  0,005  Phosphodiesterase 11A inhibitor
0,190  0,015  Breast cancer-resistant protein inhibitor
0,215  0,039  Antineoplastic (carcinoma)
0,190  0,015  5 Hydroxytryptamine agonist
0,179  0,005  Opioid mu receptor agonist
0,267  0,093  Anxiolytic
0,187  0,013  Dopamine D4 antagonist
0,246  0,074  Embryotoxic
0,178  0,007  Phosphodiesterase V inhibitor
0,186  0,017  Topoisomerase II alpha inhibitor
0,240  0,074  DNA synthesis inhibitor
0,246  0,080  Antineoplastic (non-small cell lung cancer)
0,165  0,003  Dopamine D1 agonist
0,201  0,039  UGT2B9 substrate
0,170  0,010  Female sexual dysfunction treatment
0,200  0,042  Lipid peroxidase inhibitor
0,166  0,009  Phosphodiesterase 5A inhibitor
0,177  0,021  Constipation treatment
0,221  0,066  Antiarrhythmic
0,166  0,011  5 Hydroxytryptamine 1B antagonist
0,160  0,007  Opioid agonist
0,190  0,040  Antidiarrheal
0,156  0,009  Dopamine uptake inhibitor
0,148  0,003  Dopamine autoreceptor agonist
0,162  0,020  Estrogen antagonist
0,148  0,006  Opioid kappa receptor agonist
0,148  0,006  Narcotic antagonist
0,153  0,015  Estrogen receptor beta antagonist
0,227  0,088  Tumour necrosis factor alpha release inhibitor
0,281  0,143  TNF expression inhibitor
0,146  0,009  Nicotinic alpha4beta2 receptor antagonist
0,141  0,007  Nicotinic receptor alpha7 subunit antagonist
0,137  0,003  Prolactin release inhibitor
0,148  0,015  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,225  0,093  Antineoplastic (renal cancer)
0,153  0,021  Alpha 1b adrenoreceptor antagonist
0,200  0,070  Antimigraine
0,217  0,091  Antineoplastic (cervical cancer)
0,137  0,012  Acetylcholine M3 receptor antagonist
0,195  0,072  5 Hydroxytryptamine 3E antagonist
0,192  0,071  Nitric oxide antagonist
0,127  0,008  5 Hydroxytryptamine 2A agonist
0,133  0,014  Acetylcholine M2 receptor antagonist
0,124  0,006  5 Hydroxytryptamine 2 agonist
0,141  0,026  DOPA decarboxylase inhibitor
0,249  0,135  Vasodilator, coronary
0,172  0,058  Melanin inhibitor
0,125  0,012  Alpha 1 adrenoreceptor agonist
0,128  0,015  Acetylcholine M4 receptor antagonist
0,188  0,077  VEGF expression inhibitor
0,129  0,018  Phosphodiesterase 6D inhibitor
0,111  0,005  5 Hydroxytryptamine 7 agonist
0,119  0,014  Sigma receptor antagonist
0,157  0,054  Antifungal enhancer
0,152  0,048  Anesthetic local
0,128  0,025  SULT1E1 substrate
0,224  0,123  Antiischemic
0,132  0,032  5 Hydroxytryptamine 2C antagonist
0,151  0,051  M18 aspartyl aminopeptidase inhibitor
0,162  0,062  Heat shock protein 90 antagonist
0,292  0,195  Antineoplastic (solid tumors)
0,128  0,031  Calcium antagonist
0,117  0,020  Estrogen receptor alpha antagonist
0,136  0,040  Butyrylcholinesterase inhibitor
0,140  0,044  Papain-like protease (SARS coronavirus) inhibitor
0,198  0,106  Aldehyde oxidase inhibitor
0,177  0,088  Cytotoxic
0,242  0,154  Immunosuppressant
0,138  0,051  Antiprotozoal (Amoeba)
0,171  0,085  Carcinogenic
0,095  0,009  Nicotinic alpha3beta2 receptor antagonist
0,107  0,022  Alpha 1d adrenoreceptor antagonist
0,154  0,069  Antidote
0,093  0,008  5 Hydroxytryptamine 1B agonist
0,144  0,060  Heat shock protein 70 antagonist
0,190  0,106  Antiprotozoal (Leishmania)
0,111  0,028  Histidine decarboxylase inhibitor
0,102  0,020  5 Hydroxytryptamine 1 agonist
0,101  0,022  5 Hydroxytryptamine 1D antagonist
0,092  0,017  5 Hydroxytryptamine 1A agonist
0,193  0,119  Hypoglycemic
0,079  0,007  5 Hydroxytryptamine 3B antagonist
0,088  0,017  Alpha tubulin antagonist
0,119  0,049  Nav1.1 sodium channel blocker
0,135  0,066  Cocaine dependence treatment
0,088  0,019  Glutamate (mGluR7) antagonist
0,129  0,060  Adenylate cyclase inhibitor
0,229  0,161  Antiprotozoal (Plasmodium)
0,184  0,116  Cytostatic
0,119  0,051  Expectorant
0,106  0,038  Phosphodiesterase I inhibitor
0,076  0,008  Factor III inhibitor
0,213  0,148  AR expression inhibitor
0,078  0,014  Nicotinic receptor alpha4 subunit antagonist
0,119  0,057  Sphingosine 1-phosphate receptor 2 agonist
0,075  0,014  Nicotinic receptor alpha3 subunit antagonist
0,084  0,023  Acetylcholine M5 receptor antagonist
0,100  0,040  ATPase (Vacuolar H+) inhibitor
0,074  0,015  5 Hydroxytryptamine 4 antagonist
0,131  0,073  Anesthetic
0,147  0,090  Heat shock protein 90 alpha antagonist
0,096  0,039  mTOR complex 2 inhibitor
0,079  0,023  Postmenopausal disorders treatment
0,098  0,042  Tocolytic
0,086  0,030  Antitreponemal
0,074  0,019  Dopamine transporter inhibitor
0,211  0,157  CTGF expression inhibitor
0,260  0,206  Alzheimer's disease treatment
0,070  0,017  Ryanodine receptor antagonist
0,089  0,036  Glutamate decarboxylase inhibitor
0,138  0,086  NOS3 expression enhancer
0,060  0,009  Phosphodiesterase 6C inhibitor
0,135  0,085  MAP3K9 inhibitor
0,095  0,045  Antiviral (Hepatitis A)
0,185  0,135  Cardiotonic
0,162  0,112  CYP2B6 inhibitor
0,108  0,060  UGT2B1 substrate
0,074  0,025  Heat shock protein 90 beta antagonist
0,057  0,010  Opioid delta receptor agonist
0,107  0,060  MAO A inhibitor
0,091  0,045  Antiprotozoal activity enhancer
0,151  0,105  Platelet adhesion inhibitor
0,153  0,110  Phobic disorders treatment
0,105  0,062  Toll-Like receptor 4 antagonist
0,134  0,092  Chemopreventive
0,081  0,039  Phosphodiesterase VI inhibitor
0,137  0,096  UGT1A4 substrate
0,119  0,079  Cyclooxygenase 3 inhibitor
0,060  0,021  5 Hydroxytryptamine 2C agonist
0,158  0,119  Antihypertriglyceridemic
0,072  0,033  Beta tubulin antagonist
0,133  0,095  Adenylate cyclase stimulant
0,053  0,016  Dopamine D5 agonist
0,091  0,054  Histamine N-methyltransferase inhibitor
0,178  0,141  Antiprotozoal (Trypanosoma)
0,045  0,009  Phosphodiesterase 6B inhibitor
0,129  0,096  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,103  0,070  Choleretic
0,177  0,145  Antiosteoporotic
0,218  0,187  Calcium channel activator
0,047  0,015  Vesicle monoamine transporter inhibitor
0,083  0,053  Acetylcholine nicotinic agonist
0,155  0,126  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,094  0,066  Creatine kinase inhibitor
0,188  0,160  UGT2B4 substrate
0,109  0,082  MAO inhibitor
0,077  0,050  SULT1A2 substrate
0,102  0,075  Cystathionine beta-synthase inhibitor
0,046  0,022  Dopamine D3 agonist
0,118  0,095  Protein kinase stimulant
0,030  0,007  Phosphodiesterase 6H inhibitor
0,030  0,007  Phosphodiesterase 6G inhibitor
0,144  0,122  Catenin beta inhibitor
0,117  0,095  Antineoplastic (uterine cancer)
0,124  0,105  Antiviral (Herpes)
0,070  0,052  Calcium channel L-type blocker
0,052  0,034  Estrogen agonist
0,180  0,162  Antineoplastic (sarcoma)
0,139  0,122  Aldehyde oxidase substrate
0,049  0,034  Topoisomerase II beta inhibitor
0,147  0,132  Anticonvulsant
0,155  0,141  Antiamyloidogenic
0,139  0,125  Clk dual-specificity kinase inhibitor
0,174  0,159  Proliferative diseases treatment
0,031  0,017  Endothelin receptor antagonist
0,102  0,089  Menstruation disorders treatment
0,110  0,097  NADPH oxidase inhibitor
0,022  0,011  Endothelin B receptor antagonist
0,060  0,049  Antiviral (Parainfluenza)
0,106  0,096  Alcohol dehydrogenase substrate
0,018  0,009  NMDA receptor phencyclidine site antagonist
0,098  0,090  Activin receptor-like kinase 4 inhibitor
0,174  0,168  Radiosensitizer
0,212  0,206  Antiprotozoal
0,055  0,051  5 Hydroxytryptamine uptake inhibitor
0,111  0,107  UGT2B15 substrate
0,019  0,016  Endothelin A receptor antagonist
0,191  0,189  Antithrombotic

